MARX Biotech Co., Ltd.
MARX Biotech Co., Ltd. engages in the online retail of men's health food and cosmeceutical products. The company was founded in 2015 and is based in New Taipei City, Taiwan.
MARX Biotech Co., Ltd. (7731) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.410x
Based on the latest financial reports, MARX Biotech Co., Ltd. (7731) has a cash flow conversion efficiency ratio of -0.410x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-87.74 Million) by net assets (NT$213.80 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
MARX Biotech Co., Ltd. - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how MARX Biotech Co., Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
MARX Biotech Co., Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MARX Biotech Co., Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
A W FOOD SERVICES OF CANADA INC
TO:AW
|
0.104x |
|
Lanvin Group Holdings Limited
NYSE:LANV
|
0.322x |
|
Cross Timbers Royalty Trust
NYSE:CRT
|
1.312x |
|
Meta Biomed Co. Ltd
KQ:059210
|
0.009x |
|
Hushan Autoparts Inc.
TW:7736
|
0.007x |
|
Karex Berhad
KLSE:5247
|
-0.005x |
|
Jin Air Co Ltd
KO:272450
|
0.154x |
|
Jai Corp Limited
NSE:JAICORPLTD
|
0.005x |
Annual Cash Flow Conversion Efficiency for MARX Biotech Co., Ltd. (2021–2024)
The table below shows the annual cash flow conversion efficiency of MARX Biotech Co., Ltd. from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$251.25 Million | NT$-107.18 Million | -0.427x | -783.83% |
| 2023-12-31 | NT$292.99 Million | NT$-14.14 Million | -0.048x | -125.63% |
| 2022-12-31 | NT$60.73 Million | NT$11.44 Million | 0.188x | +173.97% |
| 2021-12-31 | NT$65.61 Million | NT$-16.71 Million | -0.255x | -- |